The estimated Net Worth of James E Deerfield Mgmt Iii,... is at least $6.22 Milhão dollars as of 6 January 2021. James Iii owns over 151,723 units of Lumos Pharma Inc stock worth over $2,793,062 and over the last 4 years James sold LUMO stock worth over $3,425,905.
Sign up
James Iii LUMO stock SEC Form 4 insiders trading
James has made over 1 trades of the Lumos Pharma Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently James sold 151,723 units of LUMO stock worth $3,425,905 on 6 January 2021.
The largest trade James's ever made was selling 151,723 units of Lumos Pharma Inc stock on 6 January 2021 worth over $3,425,905. On average, James trades about 151,723 units every 0 days since 2021. As of 6 January 2021 James still owns at least 784,568 units of Lumos Pharma Inc stock.
You can see the complete history of James Iii stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Lumos Pharma Inc
Over the last 13 years, insiders at Lumos Pharma Inc have traded over $6,087,405 worth of Lumos Pharma Inc stock and bought 2,157,996 units worth $15,106,881 . The most active insiders traders include Seed Farm, Inc. Stine, Paul R Edick, eCharles J. Jr. Link. On average, Lumos Pharma Inc executives and independent directors trade stock every 257 days with the average trade being worth of $694,335. The most recent stock trade was executed by James E Deerfield Mgmt Iii,... on 6 January 2021, trading 151,723 units of LUMO stock currently worth $3,425,905.
What does Lumos Pharma Inc do?
lumos pharma is an clinical stage biotechnology company focused on developing therapeutics for rare diseases
What does Lumos Pharma Inc's logo look like?
Complete history of James Iii stock trades at Lumos Pharma Inc
Lumos Pharma Inc executives and stock owners
Lumos Pharma Inc executives and other stock owners filed with the SEC include:
-
Richard J. Hawkins,
CEO & Chairman -
Dr. John C. McKew Ph.D.,
Chief Scientific Officer & Pres -
Carl W. Langren,
Consultant -
Bradley J. Powers J.D.,
Chief Compliance Officer & Gen. Counsel -
Eddie L. Varnado M.B.A.,
VP of Fin. & Corp. Controller -
Eddie L. Varnado,
VP of Fin. & Corp. Controller -
Dr. David B. Karpf B.A., M.D.,
Chief Medical Officer -
Aaron Schuchart B.B.A., CPA, M.B.A.,
Chief Bus. Officer -
Lisa Miller,
Sr. Director of Investor Relations -
Lori D. Lawley CPA,
CFO & Principal Accounting Officer -
Seed Farm, Inc. Stine,
10% owner -
Charles J. Jr. Link,
Chairman of the Board & CEO -
Nicholas N. Vahanian,
Pres, Chief Medical Officer -
Gordon H Jr Link,
Chief Financial Officer -
Paul R Edick,
Director -
Joseph Saluri,
Director -
Ernest Iii Talarico,
Director -
David J. Lundquist,
Director -
Kenneth Lynn,
Exec VP of Bus Development -
Thomas A. Raffin,
Director -
Sarah Alexander,
Director -
William J. Ramsey,
Quality Assurance Officer -
James E Deerfield Mgmt Iii,...,